piracetam has been researched along with Anti-N-Methyl-D-Aspartate Receptor Encephalitis in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halbert, RK | 1 |
1 other study available for piracetam and Anti-N-Methyl-D-Aspartate Receptor Encephalitis
| Article | Year |
|---|---|
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Study.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Cyclophosphamide; Fatal Out | 2016 |